Abstract
This patent application from DuPont Merck discloses ortho-substituted biphenylsulfonyl derivatives, which are claimed to be selective prostaglandin (PG) G/H synthase-2 (cyclooxygenase-2; Cox-2) inhibitors and thus, have utility as anti-inflammatory, analgesic and antipyretic agents.